Evogene (EVGN) Short Interest Ratio & Short Volume

Short interest is the volume of Evogene shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 86,500 shares of EVGN short. Learn More on Evogene's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evogene: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Evogene saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 86,500 shares, an increase of 20.8% from the previous total of 71,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Evogene: Singular Genomics Systems, Inc. (1.73%), Spruce Biosciences, Inc. (1.46%), Femasys Inc. (8.54%), Prenetics Global Limited (0.17%), Freeline Therapeutics Holdings plc (0.58%), Viracta Therapeutics, Inc. (2.37%), Lexaria Bioscience Corp. (4.25%), NeuroOne Medical Technologies Co. (1.66%), Pluri Inc. (0.33%), CASI Pharmaceuticals, Inc. (1.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling EVGN is an investing strategy that aims to generate trading profit from Evogene as its price is falling. EVGN shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Evogene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVGN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVGN, twice per month. The most recent reporting period available is March, 31 2024.